Assays for the detection of coronavirus antibodies
Beckman Coulter announces development of tests to detect coronavirus antibodies
In response to the global COVID-19 pandemic, Beckman Coulter is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems, including the Access 2 and DxI series installed globally.
Visit our global newsroom to view the full press release.
Consent indicates that you would like to receive information about Beckman Coulter webinars, products, goods and services, including similarly related products, goods, or services from affiliate companies in the Danaher group.
By submitting your information you agree to Beckman Coulter storing your data in accordance with our Privacy Policy. Please review the Beckman Coulter Terms of Use and Privacy Policy where we explain what personal data we collect, use and share that you provide on our websites and other digital channels. If you do not agree with the collection and storage of your personal data please email Beckman Coulter at dataprivacy@beckman.com.
By submitting your information you agree to Beckman Coulter storing your data in accordance with our Privacy Policy. Please review the Beckman Coulter Terms of Use and Privacy Policy where we explain what personal data we collect, use and share that you provide on our websites and other digital channels. If you do not agree with the collection and storage of your personal data please email Beckman Coulter at dataprivacy@beckman.com.
English